Drugs / PIZV
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT03343626 | Nov 2017 → Dec 2018 | Zika virus infectious disease | Takeda | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | PIZV | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03343626 ↗ |
| Modality | Vaccine | “a purified, inactivated, Zika virus vaccine candidate” PMID 36484441 ↗ May 2023 |
| Route | Intramuscular | “administered either placebo or PIZV by intramuscular (IM) injection” NCT03343626 ↗ |